drugset / Trial / NCT00817479

Tumor Gene Expression in Women With Ovarian Cancer

NCT00817479 ↗

Phase 4 Completed 20 enrolled University of Chicago
RandomizedParallel-groupQuadruple-blindBasic science

Summary

The study objective is to compare changes in expression of glucocorticoid-induced genes that may be involved in cell survival signaling in the tumors of ovarian cancer patients before and after an intraoperative dose of 20mg dexamethasone.

Timeline

Start
2003-01
Primary completion
2013-01
Completion
2013-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexamethasone Small molecule 20 mg Intravenous

Indications